Latest antibacterial Stories

SARASOTA, Fla., May 16, 2013 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies have provided new evidence that its novel class of antimicrobials, named bisphosphocins, function through a completely unique mechanism of action involving bacterial membrane depolarization, resulting in rapid direct bacterial killing. These studies expand on previously published experiments...

CHAPEL HILL, N.C., April 24, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will present at the 12(th) Annual Needham Healthcare Conference at 1:40 p.m. EDT, Wednesday, May 1, at the Westin New York Grand Central Hotel in New York. Dr. Fernandes will discuss the company's two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA(TM)...

Bacteria evolve resistance more quickly when stronger antibiotics are used New scientific research published today in the journal PLoS Biology shows that bacteria can evolve resistance more quickly when stronger antibiotics are used. Researchers from the University of Exeter and Kiel University in Germany treated E. coli with different combinations of antibiotics in laboratory experiments. Unexpectedly they found that the rate of evolution of antibiotic resistance speeds up when...

Not enough is being done to educate those living in border communities about the long-term effects of antibiotic overuse and misuse, South Texas scientist says When thousands of experimental biology researchers gather in Boston this weekend, many of them undoubtedly will be presenting work related to the hunt for the next generation of antibiotics and how to battle back existing and emerging superbugs. But for one scientist from Texas Rio Grande Valley, it's not about what the research of...

AMSTERDAM, April 22, 2013 /PRNewswire/ -- Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts Instead of traditional treatment with antibiotics or chemical substances, vaginal infections can be treated and prevented by using Cranberry-Active tablets, developed by Dutch company Medical Brands. The company has obtained a European Class IIa Medical Device Status for its patented...

Policy update: Time dwindling to meet IDSA goal of 10 new antibiotics by 2020 Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 — and that drug was approved two and a half years ago. In a new report, published online today in Clinical Infectious Diseases,...

Brett Smith for redOrbit.com - Your Universe Online According to a new report from the Food and Drug Administration, shoppers who purchase meat may be getting more than they bargained for. In the newly released National Antimicrobial Resistance Monitoring System (NARMS) Retail Meat Annual Report, federal officials said their tests of retail meat revealed high levels of antibiotic resistant bacteria. According to the report, 87 percent of the meat the researchers tested contained...

A new broad range antibiotic, developed jointly by scientists at The Rockefeller University and Astex Pharmaceuticals, has been found to kill a wide range of bacteria, including drug-resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs, in mice. The antibiotic, Epimerox, targets weaknesses in bacteria that have long been exploited by viruses that attack them, known as phage, and has even been shown to protect animals from fatal infection by Bacillus anthracis, the...

ST. PETERSBURG, Fla., April 9, 2013 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced in-vitro study results suggesting ACTICOAT Silver-Coated Antimicrobial Dressings are bactericidal against some antibiotic resistant organisms carrying the NDM-1 enzyme, often referred to as 'superbugs'. An in-vitro laboratory study showed ACTICOAT Dressings, containing patented Nanocrystalline Silver technology, can kill the antibiotic...

SALT LAKE CITY, UT, March 19, 2013 /PRNewswire/ - ABL Medical, LLC has officially launched their new SilvrSTAT® Antibacterial Wound Dressing Gel into the United States market. SilvrSTAT® is the first of a new class of medical products based on the company's patented nano-molecular silver technology. ABL Medical's new SilvrSTAT® is cleared as a 510(k) medical device for the use in the management of 1st and 2nd degree burns, wounds such as stasis ulcers, pressure ulcers,...